TOR kinase and ran are downstream from PI3K/Akt in H2O2-induced mitosis

被引:42
|
作者
Radisavljevic, ZM [1 ]
González-Flecha, B [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Physiol Program, Boston, MA 02115 USA
关键词
mitosis; signaling; Akt; mTOR; Ran;
D O I
10.1002/jcb.20037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydrogen peroxide (H2O2) activates signaling cascades essential for cell proliferation via phosphaticly-linositol-3-kinase (PI3K) and Akt. Here we show that induction of mitogenic signaling by H2O2 activates sequentially PI3K, Akt, mammalian target of rapamycin (mTOR), and Ran protein. Akt activation is followed by signaling through the mTOR kinase and upregulation of Ran in primary type II pneumocytes, a cell type implicated in the development of lung adenocarcinoma. Pretreatment of the cells with wortmannin, a specific inhibitor of PI3K, or rapamycin, a specific inhibitor of mTOR kinase, prevented H2O2-increased mitosis. H2O2-induced Akt ser-473 phosphorylation and upregulation of Ran protein were prevented by wortmannin but not by rapamycin, indicating that PI3K is upstream of Akt and mTOR is downstream from Akt. Overexpression of myr-Akt or Ran-wt in type II pneumocytes increased Akt ser-473 phosphorylation and mitosis in a catalase-dependent manner, indicating that H2O2 is essential for Akt and Ran signaling. These results indicate that H2O2-induced mitogenic signaling in primary type 11 pneumocytes is mediated by PI3K, Akt, mTOR-kinase, and Ran protein. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:1293 / 1300
页数:8
相关论文
共 50 条
  • [1] Tectorigenin protect HUVECs from H2O2-induced oxidative stress injury by regulating PI3K/Akt pathway
    Chen, Xiao
    Zhang, Weijia
    Sun, Lirui
    Lian, Yonghong
    TISSUE & CELL, 2021, 68
  • [2] Daurisoline attenuates H2O2-induced chondrocyte autophagy by activating the PI3K/Akt/mTOR signaling pathway
    Zhang, Yang
    Liu, Wenguang
    Liu, Zhonghao
    Liu, Yi
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2023, 18 (01)
  • [3] Daurisoline attenuates H2O2-induced chondrocyte autophagy by activating the PI3K/Akt/mTOR signaling pathway
    Yang Zhang
    Wenguang Liu
    Zhonghao Liu
    Yi Liu
    Journal of Orthopaedic Surgery and Research, 18
  • [4] Corin protects H2O2-induced apoptosis through PI3K/AKT and NF-κB pathway in cardiomyocytes
    Li, Yansong
    Xia, Jingwen
    Jiang, Nianxin
    Xian, Yuqiong
    Ju, Haining
    Wei, Yong
    Zhang, Xuan
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 97 : 594 - 599
  • [5] Isoorientin ameliorates H2O2-induced apoptosis and oxidative stress in chondrocytes by regulating MAPK and PI3K/Akt pathways
    Cui, Tiehan
    Lan, Yun
    Lu, Yuying
    Yu, Fei
    Lin, Suai
    Fu, Yizhe
    Qiu, Jiaxuan
    Niu, Guangliang
    AGING-US, 2023, 15 (11): : 4861 - 4874
  • [6] Metformin attenuates H2O2-induced osteoblast apoptosis by regulating SIRT3 via the PI3K/AKT pathway
    Yang, Keda
    Pei, Lei
    Zhou, Siming
    Tao, Lin
    Zhu, Yue
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (05)
  • [7] TDCPP protects cardiomyocytes from H2O2-induced injuries via activating PI3K/Akt/GSK3β signaling pathway
    Weishan Zhang
    Xin Hou
    Mengjun Huang
    Xixi Zeng
    Xiju He
    Yanhong Liao
    Molecular and Cellular Biochemistry, 2019, 453 : 53 - 64
  • [8] TDCPP protects cardiomyocytes from H2O2-induced injuries via activating PI3K/Akt/GSK3β signaling pathway
    Zhang, Weishan
    Hou, Xin
    Huang, Mengjun
    Zeng, Xixi
    He, Xiju
    Liao, Yanhong
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2019, 453 (1-2) : 53 - 64
  • [9] Rutin attenuates H2O2-induced oxidation damage and apoptosis in Leydig cells by activating PI3K/Akt signal pathways
    Sun, Jianhua
    Wang, Heng
    Liu, Bei
    Shi, Wenhao
    Shi, Juanzi
    Zhang, Zhou
    Xing, Junping
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 88 : 500 - 506
  • [10] Wogonin inhibits H2O2-induced angiogenesis via suppressing PI3K/Akt/NF-κB signaling pathway
    Zhou, Mi
    Song, Xiuming
    Huang, Yujie
    Wei, Libin
    Li, Zhiyu
    You, Qidong
    Guo, Qinglong
    Lu, Na
    VASCULAR PHARMACOLOGY, 2014, 60 (03) : 110 - 119